Antibiotics Are NOT Indicated for Gouty Arthritis
Antibiotics have no role in the treatment of acute or chronic gouty arthritis, as gout is a crystal-induced inflammatory arthritis, not an infectious condition. 1
Standard Treatment for Acute Gouty Arthritis
The established first-line pharmacologic options for treating acute gout flares are 1:
- NSAIDs (naproxen, indomethacin, or sulindac at full anti-inflammatory doses)
- Colchicine (1.2 mg loading dose followed by 0.6 mg one hour later, initiated within 36 hours of symptom onset)
- Corticosteroids (oral prednisone 0.5 mg/kg/day for 5-10 days, or intra-articular injection for 1-2 large joints)
Treatment should be initiated within 24 hours of acute attack onset for optimal effectiveness 1.
When Antibiotics ARE Indicated in Rheumatologic Conditions
Antibiotics should only be used for rheumatologic diseases with proven infectious etiology 2:
- Lyme arthritis (doxycycline, amoxicillin, or cefuroxime axetil for 28 days) 1
- Rheumatic fever (treatment and prevention of recurrence)
- Reactive arthritis (early administration may be considered)
- Whipple's disease
Critical Distinction: Septic Arthritis vs. Gouty Arthritis
Common pitfall: If a patient presents with acute monoarticular arthritis and there is clinical concern for septic arthritis (fever, immunosuppression, recent joint instrumentation, inability to bear weight), joint aspiration with synovial fluid analysis is mandatory 1. In this scenario:
- Antibiotics are indicated for septic arthritis (bacterial infection)
- Antibiotics are NOT indicated for gouty arthritis (crystal deposition)
- Synovial fluid analysis showing monosodium urate crystals confirms gout
- Synovial fluid with positive Gram stain or culture confirms infection
Evidence Quality
The 2012 ACR guidelines 1, 2016 EULAR recommendations 1, and 2020 ACR guideline 1 consistently recommend anti-inflammatory agents (NSAIDs, colchicine, corticosteroids) as first-line therapy for gout flares, with no mention of antibiotics having any therapeutic role. The recent 2025 critical review explicitly states antibiotics should only be used for rheumatologic diseases with clear infectious etiology, which does not include gout 2.
Severe or Refractory Cases
For patients with inadequate response to initial therapy, the recommended escalation includes 1:
- Combination therapy (colchicine + NSAIDs, or colchicine + corticosteroids)
- IL-1 inhibitors (anakinra, canakinumab) for refractory cases
- Never antibiotics, as they provide no benefit for crystal-induced inflammation